Kardiologische Diagnostik bei asymptomatischen Patienten mit Diabetes

ZUSAMMENFASSUNG

Der Diabetes mellitus ist mit einem erhöhten Risiko für kardiovaskuläre Erkankungen assoziiert. Die aktuellen Leitlinien der European Society of Cardiology (ESC) und der American Heart Association (AHA) sprechen sich gegen ein Routinescreening aller Diabetiker aus und empfehlen stattdessen abhängig von weiteren Risikofaktoren ein differenziertes Vorgehen. Hierbei können Biomarker, Kardio-CT, Stressbildgebung und Risikorechner helfen, jedoch hat bisher keines dieser Untersuchungen beim asymptomatischen Diabetiker in Studien eine Überlegenheit zeigt.

• 1 Emerging Risk Factors Collaboration1. Sarwar N. Gao P. Seshasai SR. Gobin R. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222
• 2 Carson AP. Tanner RM. Yun H. et al. Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes. Ann Epidemiol 2014; 24: 581-587
• 3 Bulugahapitiya U. Siyambalapitiya S. Sithole J. Idris I. Is diabetes a coronary risk equivalent?. Systematic review and meta-analysis. Diabet Med 2009; 26: 142-148
• 4 Greenland P. Alpert JS. Beller GA. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010; 122: e584-636
• 5 Perk J. De Backer G. Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701
• 6 Chamnan P. Simmons RK. Sharp SJ. et al Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia 2009; 52: 2001-2014
• 7 Scirica BM. Bhatt DL. Braunwald E. et al. Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol 2016; 1: 989-998
• 8 Wong ND. Rozanski A. Gransar H. et al. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 2005; 28: 1445-1450
• 9 Raggi P. Shaw LJ. Berman DS. Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004; 43: 1663-1669
• 10 Cortigiani L. Bigi R. Sicari R. et al. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 2006; 47: 605-610
• 11 Anand DV. Lim E. Hopkins D. et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 2006; 27: 713-721
• 12 Budoff MJ. Raggi P. Beller GA. et al. Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology. JACC Cardiovasc Imaging 2016; 9: 176-192
• 13 Muhlestein JB. Lappé DL. Lima JA. et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 2014; 312: 2234-2243
• 14 Rydén L. Grant PJ. Anker SD. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34: 3035-3087
• 15 Young LH. Wackers FJ. Chyun DA. et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009; 301: 1547-1555